Drug intelligence / Profile preview

Xinnaining Capsule

Development stage
Unknown
Lead developer
Guizhou Jingcheng Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Xinnaining Capsule (also commonly transliterated as Xinnaoning Capsule) is a traditional Chinese patent medicine (CPM) formulated from five active herbal ingredients: *Ginkgo biloba* L. (Ginkgo Leaf), *Buxus sinica* var. *parvifolia* (Boxwood Leaf), *Salvia miltiorrhiza* Bunge (Danshen), *Cinnamomum migao* H.W. Li (Fructus Cinnamomum migao), and *Allium macrostemon* Bunge (Longstamen Onion Bulb). It is developed and manufactured by Guizhou Jingcheng Pharmaceutical, a subsidiary of Jingfeng Pharmaceutical (which is controlled by CSPC Pharmaceutical Group). Xinnaining Capsule is indicated for promoting Qi and blood circulation, resolving blood stasis, and relieving pain. It is widely prescribed in China for the treatment of cardiovascular and cerebrovascular diseases, including coronary heart disease, chronic stable angina pectoris, acute coronary syndrome (ACS), cerebral arteriosclerosis, and carotid artery plaque.

Other names
Xin-Nao-Ning CapsuleXinnaoning Capsule心脑宁胶囊

Beyond the preview

Go deeper on Xinnaining Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xinnaining Capsule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call